A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

NCT03274817 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Insufficient Enrollment

Conditions

Alzheimer Disease

Interventions

DRUG: Escitalopram Pill
DRUG: Venlafaxine Pill
DRUG: Placebo Oral Tablet

Sponsor

NYU Langone Health